The Atopic March: The Pattern of Allergic Disease Development in Childhood

https://doi.org/10.1016/j.iac.2005.02.004Get rights and content

Section snippets

The atopic march

Parents and clinicians have long recognized that the various manifestations of atopic disease often present in a characteristic sequence, referred to as the atopic march, and such a pattern has been confirmed by prospective birth-cohort studies [3], [4], [5]. Allergic disease manifestations are rare during the first month of life. The initial signs of allergic disease are atopic dermatitis and food allergies, which typically have their greatest incidence peaks during the first 2 years of life.

Defining the populations at risk

Multiple prospective cohort studies have identified factors that predispose individuals to the development of atopic disease (Table 1). Effective early identification of children at risk for the development of allergic disease may allow focused interventions in an attempt to decrease the likelihood of developing atopic disease. Numerous features thought to be related to or predictive of the development of atopic disease have been investigated, including family history, cord blood IgE levels,

Mechanisms and the genetic basis for the atopic march

The association of family history, allergic sensitization, and personal history of atopic disease suggests an underlying genetic predisposition. Linkage studies in several populations have attempted to elucidate the genetic etiology of the atopic march. Multiple genetic loci are associated with various phenotypes of atopic disease, and three genetic loci are associated with both atopic dermatitis and asthma (5q31-33, 11q13, and 13q12-14) [25]. This finding is consistent with the recognized

Prevention of the atopic march

Current treatment of allergic disease remains largely symptomatic and aimed at controlling the underlying allergic process, because most treatment approaches lack disease-modifying properties. Thus, there continues to be intense interest in strategies aimed at the prevention of atopic diseases in infants, especially those with familial and, thus, genetic risk. Prevention approaches can be categorized by the population at risk and the degree of disease manifestation at the time of intervention.

Summary

Clinical impressions and numerous clinical studies confirm the occurrence of an atopic march. A multitude of risk factors and treatment modalities have been evaluated in efforts to define the populations at risk and to alter the development of allergic disorders in the context of the rising prevalence of allergic disorders during the past several decades. It is evident that genetic background plays an important role, although environmental factors also contribute significantly, and these

First page preview

First page preview
Click to open first page preview

References (51)

  • T. Schafer et al.

    Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren

    J Allergy Clin Immunol

    (1999)
  • S. Illi et al.

    The natural course of atopic dermatitis from birth to age 7 years and the association with asthma

    J Allergy Clin Immunol

    (2004)
  • K. Falth-Magnusson et al.

    Allergy prevention by maternal elimination diet during late pregnancy—a 5-year follow-up of a randomized study

    J Allergy Clin Immunol

    (1992)
  • U. Saarinen et al.

    Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old

    Lancet

    (1995)
  • M. Gdalevich et al.

    Breast-feeding and the risk of bronchial asthma in childhood: a systematic review with meta-analysis of prospective studies

    J Pediatr

    (2001)
  • M. Gdalevich et al.

    Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies

    J Am Acad Dermatol

    (2001)
  • M. Kalliomaki et al.

    Probiotics and prevention of atopic disease: 4-year follow up of a randomised placebo-controlled trial

    Lancet

    (2003)
  • J. Warner

    A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up

    J Allergy Clin Immunol

    (2001)
  • S. Rak et al.

    The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

    J Allergy Clin Immunol

    (1988)
  • C. Moller et al.

    Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)

    J Allergy Clin Immunol

    (2002)
  • A. Custovic et al.

    Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial

    Lancet

    (2001)
  • E. von Mutius

    The rising trends in asthma and allergic disease

    Clin Exp Allergy

    (1998)
  • W.M. Vollmer et al.

    20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO

    Am J Respir Crit Care Med

    (1998)
  • J. Yunginger et al.

    A community-based study of the epidemiology of asthma

    Am Rev Respir Dis

    (1992)
  • U. Wahn

    What drives the allergic march?

    Allergy

    (2000)
  • Cited by (102)

    • Beyond the Skin: Reduced Lung Function Associated With Atopic Dermatitis in Infants

      2023, Journal of Allergy and Clinical Immunology: In Practice
    • Maternal Perinatal Dietary Patterns Affect Food Allergy Development in Susceptible Infants

      2019, Journal of Allergy and Clinical Immunology: In Practice
    View all citing articles on Scopus
    View full text